Friday, September 11, 2009

Dr. Douglas Spouts Off on the Flu Shot

You will need to take strong defensive action if you are forced to take a flu shot. This will not be a normal flu shot. Dr. Douglass' recommendations are a good place to start.
 

How many shots are enough?

I was suspicious the moment I heard the talk of mass vaccinations for swine flu.

But now that they're saying people may need as many as four flu shots this year, I'm no longer just suspicious -- the lights are flashing and all my warning bells are ringing at full volume.

I don't quite know just what they're up to yet -- but I'm pretty sure it has little to do with that weapon of mass distraction known as swine flu.

Apparently, health officials still know so little about the swine flu vaccine that they don't even know how many shots people will need in order for it to be effective.

Welcome to your new life as a lab rat.

On top of that pig needle, they want everyone to get the regular flu shot. And if you've never had a flu shot before, well then, you should get two. .

It's enough to make your head spin -- or at least sprout a curly tail and start squealing.

We've had other disease panics in recent years, some far worse than swine flu, yet there was never any talk about mass forced vaccinations before, much less three or four jabs in a row.

There hasn't been a forced vaccination scheme on this scale since the polio shots of the 1950s, but school officials are buying into the panic, hook, line and oinker. Why is it that some of the least educated people always end up in charge of education?

I've already told you what you can do to protect yourself if you're forced to get a swine flu shot. The same goes for your kids, too.

Wiping the lipstick off the pig,

William Campbell Douglass II, M.D.

NYSE Arca Morning Update - 08:30:00 ET

NYSE Arca Morning Update for Friday, Sep 11, 2009 :

STOCKS TRADING ON NYSE Arca AT A PRICE 15% OR MORE AWAY FROM
THE PREVIOUS TRADE DAY'S CONSOLIDATED CLOSE PRICE (AS OF 08:30:00 ET)

Stock Thursday's Close Current Price Pct Change Current NYSE ARCA Vol
SPDE $2.50 $3.74 49.4% 2,100
CMRO $2.06 $2.79 35.4% 1,998
AXL $6.32 $7.48 18.4% 127,784
QDEL $16.69 $19.34 15.9% 9,621


10 MOST ACTIVE STOCKS ON NYSE ARCA AS OF 08:30:00 ET

BASED ON DOLLARS TRADED: | BASED ON SHARES TRADED:
Stock $ Volume Price PctChg | Stock Share Vol Price PctChg
SPY $23,392,473 $104.77 ( 0.0%) | C 844,438 $4.73 ( 0.3%)
GLD $14,989,910 $98.19 0.6% | DSCO 317,150 $0.77 60.4%
GS $8,249,448 $176.56 0.9% | SPY 223,232 $104.77 ( 0.0%)
BHP $6,960,105 $67.20 1.8% | BAC 200,273 $17.21 ( 0.1%)
CREE $6,527,394 $36.34 ( 1.1%) | CREE 178,164 $36.34 ( 1.1%)
AIG $5,933,068 $36.90 ( 2.2%) | UNG 170,844 $11.03 ( 1.3%)
BBL $4,972,462 $57.32 2.2% | AIG 161,979 $36.90 ( 2.2%)
C $3,997,141 $4.73 ( 0.3%) | LVS 155,297 $16.68 2.9%
BAC $3,449,744 $17.21 ( 0.1%) | GLD 152,533 $98.19 0.6%
MT $3,081,444 $39.81 3.5% | AXL 127,784 $7.48 18.4%


Price changes may be affected by symbol splits and dividends.

Consolidated close price is the last print (excluding prints with trade
conditions) prior to 4PM ET.

This information is also updated on our web page every morning at 8:35ET:
http://www.tradearca.com/data/volume/daily_update.asp

This material is for informational purposes only.
NYSE Euronext and its affiliates ("NYSE Arca") are not soliciting any action based upon it.
This material is not to be construed as an offer to buy or sell any security in any jurisdiction where such an offer or solicitation would be illegal.
Any opinions expressed in this material are NYSE Arca opinions only.
NYSE Arca undertakes no obligation to update any of the information contained in this material in light of new information or future events.
THIS MATERIAL IS PROVIDED BY NYSE ARCA "AS IS" AND WITHOUT WARRANTIES EXPRESS OR IMPLIED.
NYSE ARCA DISCLAIMS ALL WARRANTIES INCLUDING THE IMPLIED WARRANTIES OF MERCHANTIBILITY, TITLE, AND FITNESS FOR A PARTICULAR PURPOSE AS TO THIS MATERIAL.
IN NO EVENT SHALL NYSE ARCA BE LIABLE FOR DIRECT, INDIRECT, INCIDENTAL, PUNITIVE, OR CONSEQUENTIAL DAMAGES OF ANY KIND WHATSOEVER (INCLUDING BUT NOT LIMITED TO, LOST PROFITS, TRADING LOSSES AND DAMAGES THAT MAY RESULT FROM THE USE
OF THIS MATERIAL, ANY DELAY OR INTERRUPTION OF SERVICE OR OMISSIONS OR INACCURACIES IN THE MATERIAL) WITH RESPECT TO THIS MATERIAL.

Copyright [2009] by NYSE Euronext. All rights reserved. Reproduction and redistribution prohibited without prior express consent.

Subscribe to "The $t0ckman" via email

Enter your email address:

Delivered by FeedBurner